Epigenomics AG Profile Avatar - Palmy Investing

Epigenomics AG

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The co…
Medical - Diagnostics & Research
DE, Berlin [HQ]
EPGNF/Financials
Segments · Problems · Premarket · Compliance

Segment Analysis

Segment Analysis
Revenue · By Business Segment
Not available for EPGNF
Revenue · By Area
Not available for EPGNF
End of EPGNF's Analysis
CIK: - CUSIP: - ISIN: DE000A37FT41 LEI: - UEI: -
Secondary Listings
EPGNF has no secondary listings inside our databases.